Paragon Care Ltd
Paragon Care Ltd operates in the healthcare services and equipment sector, providing medical equipment, supplies, and distribution services.
Business. Paragon Care Ltd (PGC.AX) is an Australian company primarily engaged in the banking industry. The firm is listed on the Australian Securities Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the financial services sector.
Analyst recommendations
2 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Paragon Care Ltd (PGC.AX) is an Australian company primarily engaged in the banking industry. The firm is listed on the Australian Securities Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data. Consequently, the company is described at the industry level as a participant in the financial services sector.
- Paragon Care Ltd's liquidity and capital structure cannot be assessed due to missing balance-sheet data.
- Profitability and returns metrics are not available, preventing a comparison to industry benchmarks.
- No segment or geographic exposure data is disclosed, limiting visibility into revenue concentration.
- Growth trajectory and outlook data are not available, making it difficult to assess future performance.
- Dilution risk is currently low, but the absence of financial data limits the ability to evaluate other risk factors.
Bull / Bear case
Generated · model-assistedRevenue surged 21.7% year-over-year to AUD 3.62 billion in FY2025, demonstrating strong top-line growth momentum.
Net income more than doubled with a 151.5% year-over-year increase to AUD 20.6 million in FY2025.
Free cash flow rebounded sharply, rising 473.0% year-over-year to AUD 33.5 million in FY2025.
Analysts assign a strong buy rating with a mean price target of AUD 0.325, implying 116.7% upside.
Operating income nearly doubled, increasing 96.9% year-over-year to AUD 58.6 million in FY2025.
Long-term debt increased significantly to AUD 292.5 million in FY2025, reflecting a high leverage band.
The debt-to-equity ratio stands at 10.43, indicating substantial financial leverage and potential solvency risks.
Free cash flow was negative AUD 9.0 million in FY2024, showing recent volatility in cash generation.
Top five institutional holders represent 0.0% of ownership, suggesting low institutional conviction or concentration.
In focus — financials by report
Revenue A$3.62B, +21,7% YoY; Operating income +96,9% YoY.
- ▍Revenue A$3.62B, +21,7% YoY
- ▍Operating income +96,9% YoY
- ▍Net income +151,5% YoY
- ▍Free cash flow +473,0% YoY
- ▍Net margin 0.6%
Revenue A$2.97B, +35,9% YoY; Operating income +2,5% YoY.
- ▍Revenue A$2.97B, +35,9% YoY
- ▍Operating income +2,5% YoY
- ▍Net income −35,2% YoY
- ▍Free cash flow −185,0% YoY
- ▍Net margin 0.3%
Revenue A$2.19B, +820,0% YoY; Operating income +81,4% YoY.
- ▍Revenue A$2.19B, +820,0% YoY
- ▍Operating income +81,4% YoY
- ▍Net income +96,4% YoY
- ▍Free cash flow +6,7% YoY
- ▍Net margin 0.6%
Revenue A$237.8M, +0,8% YoY; Operating income −21,2% YoY.
- ▍Revenue A$237.8M, +0,8% YoY
- ▍Operating income −21,2% YoY
- ▍Net income −22,4% YoY
- ▍Free cash flow +8,0% YoY
- ▍Net margin 2.7%
Revenue A$235.9M; Operating income A$20.3M.
- ▍Revenue A$235.9M
- ▍Operating income A$20.3M
- ▍Net margin 3.5%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,02 |
| Revenue | —no estimate | —no estimate | 3,7B AUD |
| Operating income | —no estimate | —no estimate | 67,3M AUD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- EVP, Chief Credit Officer · Phantom Stock → Common StockDisposed 326exercise · 2026-03-20
- SEVP & Chief Financial Officer · Restricted Stock Units → Common StockAcquired 11 113grant · 2026-03-20
- SEVP & Chief Financial Officer · Restricted Stock Units → Common StockAcquired 7 408grant · 2026-03-20
- SEVP & Chief Financial Officer · Restricted Stock Units → Common StockDisposed 1 666exercise · 2026-03-20
- SEVP & Chief Financial Officer · Restricted Stock Units → Common StockDisposed 1 615exercise · 2026-03-20
- EVP, Chief Credit Officer · Phantom Stock → Common StockDisposed 2 112exercise · 2026-03-20
- EVP, Chief Credit Officer · Restricted Stock Units → Common StockAcquired 1 928grant · 2026-03-20
- EVP, Chief Credit Officer · Restricted Stock Units → Common StockDisposed 1 795exercise · 2026-03-20
- EVP, Chief Credit Officer · Restricted Stock Units → Common StockDisposed 1 560exercise · 2026-03-20
- EVP, Chief Credit Officer · Restricted Stock Units → Common StockAcquired 5 785grant · 2026-03-20
- EVP, Chief Credit Officer · Restricted Stock Units → Common StockDisposed 1 633exercise · 2026-03-20
- EVP, Comm & Ind Lndg · Phantom Stock → Common StockDisposed 943exercise · 2026-03-20
- EVP, Comm & Ind Lndg · Phantom Stock → Common StockDisposed 2 378exercise · 2026-03-20
- EVP, Comm & Ind Lndg · Restricted Stock Units → Common StockAcquired 2 339grant · 2026-03-20
- EVP, Comm & Ind Lndg · Restricted Stock Units → Common StockDisposed 1 955exercise · 2026-03-20
- EVP, Comm & Ind Lndg · Restricted Stock Units → Common StockDisposed 1 699exercise · 2026-03-20
- EVP, Comm & Ind Lndg · Restricted Stock Units → Common StockDisposed 1 359exercise · 2026-03-20
- EVP, Comm & Ind Lndg · Restricted Stock Units → Common StockAcquired 7 016grant · 2026-03-20
- EVP, Comm & Ind Lndg · Restricted Stock Units → Common StockDisposed 1 856exercise · 2026-03-20
- SEVP, President Comml Banking · Phantom Stock → Common StockDisposed 754exercise · 2026-03-20
- SEVP, President Comml Banking · Phantom Stock → Common StockDisposed 1 801exercise · 2026-03-20
- SEVP, President Comml Banking · Restricted Stock Units → Common StockAcquired 10 294grant · 2026-03-20
- President & CEO · Restricted Stock Units → Common StockDisposed 3 674exercise · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Restricted Stock Units → Common StockDisposed 2 514exercise · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Restricted Stock Units → Common StockAcquired 9 362grant · 2026-03-20
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Paragon Care Ltd Market data — financials · 2026-05-28
- Paragon Care Ltd Market data — analyst estimates · 2026-05-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,01 %$36M
- Investment Managers · as of 2026-03-310,01 %$13M
- Investment Managers · as of 2026-03-310,00 %$22M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$7M
- Investment Managers · as of 2024-06-300,00 %$39M
- Investment Managers · as of 2026-03-310,00 %$14M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$18M
- Investment Managers · as of 2024-12-310,00 %$2M
- Investment Managers · as of 2025-12-310,00 %$27M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$1M
- Funds · as of 2026-03-310,00 %$1M
- Institutional Investor · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$2M
- Institutional Investor · as of 2026-03-310,00 %$2M
- Investment Managers · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
- Brokerage Firms · as of 2026-03-310,00 %$0M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Doug L. KennedyPresident, Chief Executive Officer, Director
Insider activity
- SVP/Chief Accounting Officer · Common StockSold 1 937 @ $45,52$88K · 2026-06-11
- SVP/Chief Accounting Officer · Common StockSold 547 @ $45,52$25K · 2026-06-11
- Director · Common StockSold 2 000 @ $44,63$89K · 2026-06-08
- SEVP & Chief Financial Officer · Common StockBought 2 890 @ $34,95$101K · 2026-03-31
- Director · Common StockBought 1 430 @ $34,97$50K · 2026-03-30
- President & CEO · Common StockBought 11 296 @ $35,21$398K · 2026-03-30
- EVP, Chief Operating Officer · Common StockOther 5 616 · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 1 760 · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 901 @ $33,18$30K · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 1 258 · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 644 @ $33,18$21K · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 1 197 · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 613 @ $33,18$20K · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 6 199 · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 2 178 @ $33,18$72K · 2026-03-20
- SEVP & Pres of Priv Wealth Mgt · Common StockOther 754 · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 699 · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 220 @ $33,18$7K · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 1 232 · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 387 @ $33,18$13K · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 1 418 · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 445 @ $33,18$15K · 2026-03-20
- EVP & Chief Risk Officer · Common StockOther 942 · 2026-03-20
- President & CEO · Common StockOther 3 896 · 2026-03-20
- President & CEO · Common StockOther 1 993 @ $33,18$66K · 2026-03-20
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 13.4%Derived (calculated)
- Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 7.2%Derived (calculated)
- Total assets (YoY) (2025-12-31 vs 2024-12-31): 7.3%Derived (calculated)
- Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 8.6%Derived (calculated)
- Revenue (YoY) (2025-12-31 vs 2024-12-31): 24.1%Derived (calculated)
- Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -39.3%Derived (calculated)
- Net income (YoY) (2025-12-31 vs 2024-12-31): 13.2%Derived (calculated)
- Capex (YoY) (2025-12-31 vs 2024-12-31): 76.8%Derived (calculated)
- Net margin (FY 2025-12-31): 13.2%Derived (calculated)
- Return on equity (FY 2025-12-31): 5.7%Derived (calculated)
- Return on assets (FY 2025-12-31): 0.5%Derived (calculated)
- Debt-to-equity (FY 2025-12-31): 10.43xDerived (calculated)
- EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 13.5%Derived (calculated)
- Revenue (annual): USD 283MSEC XBRL filing
- Operating cash flow (annual): USD 43.13MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES 2SEC XBRL filing
- Shareholders' equity (annual): USD 658.21MSEC XBRL filing
- Total liabilities (annual): USD 6.87BSEC XBRL filing
- Capex (annual): USD 14.32MSEC XBRL filing
- Shares outstanding (annual): 17.56MSEC XBRL filing
- EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
- Net income (annual): USD 37.33MSEC XBRL filing
- Pre-tax income (annual): USD 52.31MSEC XBRL filing
- Total assets (annual): USD 7.53BSEC XBRL filing